New drug trial targets debilitating itch for dialysis patients
NCT ID NCT04711603
Summary
This study tested whether an investigational drug called MR13A9 could reduce severe itching in people receiving hemodialysis for kidney disease. The trial involved 178 patients who experienced significant itch despite treatment. Researchers compared MR13A9 against a placebo to see if it provided better relief over four weeks, then monitored long-term safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UREMIC PRURITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.